OGN logo

Organon & Co (OGN) Company Overview

Profile

Full Name:

Organon & Co.

Sector:

Healthcare

Industry:

Drug Manufacturers - General

Country:

United States

IPO:

May 14, 2021

Indexes:

Not included

Website:

http://www.organon.com

Description:

Organon & Co is a global healthcare company focused on women's health, biosimilars, and other medicines. They develop and provide treatments for various health issues, aiming to improve the lives of women and patients worldwide. Their mission is to empower people to live healthier lives.

Key Details

Price

$15.75

Market Cap

$4.06 B(Mid cap)

Last Dividend

$0.28

TTM Dividend Yield

7.11%

Annual Revenue

$6.40 B(+2.24% YoY)

Annual EPS

$3.33(-16.54% YoY)

PE Ratio

4.73

Annual ROE

429.85%

Annual Debt To Equity

18.81

Beta

0.54

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Feb 13, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 24, 2025
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 14, 25 Morgan Stanley
Equal-Weight
Feb 14, 25 Barclays
Overweight
Sep 6, 24 JP Morgan
Underweight
May 6, 24 Goldman Sachs
Neutral
May 3, 24 Goldman Sachs
Neutral
Apr 29, 24 Piper Sandler
Overweight
Feb 20, 24 Goldman Sachs
Neutral
Nov 22, 23 Piper Sandler
Overweight
Nov 3, 23 Goldman Sachs
Neutral
Oct 25, 23 Piper Sandler
Overweight

Screeners with OGN included

Growing Shares Outstanding
Mid cap stocks
US stocks
Stocks below SMA 200
Stocks recommended to hold
Best performing stocks last 3 months
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
Companies with growing dividends

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$15.75
OGN price is $15.75

Price All-time High

$39.36
OGN price is currently -59.98% below its historical high of $39.36

Price Analysts Target

$19.00
OGN price is currently -17.11% lower than the consensus analysts' forecast

Price Today Change

+0.13%
OGN price is up +0.13% today

Price YTD Change

+5.49%
OGN price is up +5.49% since January 1st

Price 3-Year Change

-56.04%
OGN price is down -56.04% over the past 3 years

Market cap

Market Cap

$4.06 B
OGN market capitalization is $4.06 billion

Market Cap 3-Year Change

-55.28%
OGN market capitalization is down -55.28% over the past 3 years

Market Cap All-time High

$9.98 B
OGN market capitalization is currently -59.29% below its historical high of $9.98 billion

Market Cap Sector Rank

87.98%
OGN market capitalization is higher than 87.98% of companies in Healthcare sector

Technical

Beta

0.54
OGN beta is 0.54

200-day SMA

$18.14
OGN price is currently -13.17% below its 200-day simple moving average

14-day RSI

54.95
OGN 14-day relative strength index is 54.95

30-day Relative Volume

1.25
OGN 30-day relative volume is 1.25

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.28
OGN last dividend was $0.28 per share, with an ex-dividend date of February 24, 2025

Next Dividend

-
OGN next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$1.12
OGN annual dividend per share is $1.12

Annual Dividend Per Share Sector Rank

48.24%
OGN annual dividend per share is higher than 48.24% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

0%
OGN {parameterFullLabel} has remained unchanged year-on-year

Annual Dividend Per Share 3-Year Change

+100%
OGN annual dividend per share is up +100% over the past 3 years

Dividend yield

Annual Dividend Yield

7.11%
OGN annual dividend yield is 7.11%

Annual Dividend Yield Sector Rank

89.29%
OGN annual dividend yield is higher than 89.29% of companies in Healthcare sector

Other

Annual Payout Ratio

34.38%
OGN annual payout ratio is 34.38%

Annual Dividends Paid

$297.00 M
OGN annual dividends paid is $297.00 million

Annual FCF

$588.00 M
OGN annual free cash flow is $588.00 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$6.40 B
OGN annual revenue is $6.40 billion

Annual Revenue Analysts Estimate

$6.29 B
OGN annual revenue is currently +1.80% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

+2.24%
OGN annual revenue is up +2.24% year-on-year

Annual Revenue Sector Rank

92.66%
OGN annual revenue is higher than 92.66% of companies in Healthcare sector

Profit

Annual Gross Profit

$3.71 B
OGN annual gross profit is $3.71 billion

Annual Gross Margin

58.02%
OGN annual gross profit margin is 58.02%

Annual Operating Profit

$1.49 B
OGN annual operating income is $1.49 billion

Annual Operating Margin

23.21%
OGN annual operating profit margin is 23.21%

Annual Net Income

$864.00 M
OGN annual net profit is $864.00 million

Annual Net Margin

13.49%
OGN annual net profit margin is 13.49%

EPS

Annual EPS

$3.33
OGN annual earnings per share is $3.33

Annual EPS Analysts Estimate

$3.84
OGN annual earnings per share is currently -13.29% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-16.54%
OGN annual earnings per share is down -16.54% year-on-year

Annual EPS Sector Rank

94.24%
OGN annual earnings per share is higher than 94.24% of companies in Healthcare sector

ROA & ROE

Annual ROA

6.87%
OGN annual return on assets is 6.87%

Annual ROE

429.85%
OGN annual return on equity is 429.85%

EBIT & EBITDA

Annual EBIT

$1.33 B
OGN annual earnings before interest & taxes is $1.33 billion

Annual EBITDA

$1.33 B
OGN annual EBITDA is $1.33 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

4.73
OGN price to earnings ratio is 4.73

PE Ratio Sector Rank

6.4%
OGN price to earnings ratio is higher than 6.4% of companies in Healthcare sector

PB Ratio

PB Ratio

8.61
OGN price to book ratio is 8.61

PB Ratio Sector Rank

90.86%
OGN price to book ratio is higher than 90.86% of companies in Healthcare sector

PS Ratio

PS Ratio

0.63
OGN price to sales ratio is 0.63

PS Ratio Sector Rank

17.86%
OGN price to sales ratio is higher than 17.86% of companies in Healthcare sector

Enterprise value

Enterprise Value

$12.27 B
OGN enterprise value is $12.27 billion

Enterprise Value Sector Rank

92.78%
OGN enterprise value is higher than 92.78% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

8.03
OGN EV/EBITDA is 8.03

EV/EBITDA Sector Rank

80.3%
OGN EV/EBITDA is higher than 80.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.60
OGN annual current ratio is 1.60

Annual Quick Ratio

1.11
OGN annual quick ratio is 1.11

Leverage

Annual Debt To Equity

18.81
OGN annual debt to equity ratio is 18.81

Annual Interest Coverage Ratio

2.55
OGN annual interest coverage ratio is 2.55

Risk & Stability

Piotroski F-Score

5
OGN piotroski f-score is 5

Altman Z-Score

1.27
OGN altman z-score is 1.27

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$13.10 B
OGN annual total assets is $13.10 billion

Annual Non Current Assets

$8.75 B
OGN annual long term assets is $8.75 billion

Annual Current Assets

$4.35 B
OGN annual total current assets is $4.35 billion

Annual Cash & Cash Equivalents

$675.00 M
OGN annual cash & cash equivalents is $675.00 million

Equity

Annual Book Value

$472.00 M
OGN annual book value is $472.00 million

Annual Working Capital

$1.63 B
OGN annual working capital is $1.63 billion

Liabilities

Annual Total Liabilities

$12.63 B
OGN annual total liabilities is $12.63 billion

Annual Total Long Term Liabilities

$9.91 B
OGN annual total long term liabilities is $9.91 billion

Annual Current Liabilities

$2.72 B
OGN annual total current liabilities is $2.72 billion

Annual Accounts Payable

$1.15 B
OGN annual accounts payable is $1.15 billion

Debt

Annual Total Debt

$8.88 B
OGN annual total debt is $8.88 billion

Annual Total Debt 1-Year Change

+1.37%
OGN annual total debt is up +1.37% year-on-year

Annual Long Term Debt

$8.86 B
OGN annual long term debt is $8.86 billion

Annual Short Term Debt

$20.00 M
OGN annual short term debt is $20.00 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$4.92 B
OGN annual total expenses is $4.92 billion

Annual Operating Expenses

$2.23 B
OGN annual total operating expenses is $2.23 billion

Annual Cost Of Goods Sold

$2.69 B
OGN annual cost of goods sold is $2.69 billion

Annual SGA

$1.76 B
OGN annual SGA is $1.76 billion

Annual D&A

$277.00 M
OGN annual depreciation & amortization is $277.00 million

Annual Interest Expense

$520.00 M
OGN annual interest expense is $520.00 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$939.00 M
OGN annual cash flow from operations is $939.00 million

Annual CFO 1-Year Change

+17.52%
OGN annual cash flow from operations is up +17.52% year-on-year

Annual CFI

-$513.00 M
OGN annual cash flow from investing activities is -$513.00 million

Annual CFI 1-Year Change

-97.31%
OGN annual cash flow from investing activities is down -97.31% year-on-year

Annual CFF

-$368.00 M
OGN annual cash flow from financing activities is -$368.00 million

Annual CFF 1-Year Change

+35.33%
OGN annual cash flow from financing activities is up +35.33% year-on-year

Free CashFlow

Annual FCF

$588.00 M
OGN annual free cash flow is $588.00 million

Annual FCF 1-Year Change

+9.29%
OGN annual free cash flow is up +9.29% year-on-year

CAPEX

Annual CAPEX

$351.00 M
OGN annual capital expenditures is $351.00 million

Annual CAPEX 1-Year Change

+34.48%
OGN annual capital expenditures is up +34.48% year-on-year

Institutional Ownership

Similar stocks

ITGR logo
Integer Holdings (ITGR)
ACLX logo
Arcellx (ACLX)
PTCT logo
PTC Therapeutics (PTCT)
ADMA logo
ADMA Biologics (ADMA)
OSCR logo
Oscar Health (OSCR)
PBH logo
Prestige Consumer Healthcare (PBH)
PRGO logo
Perrigo (PRGO)
ZLAB logo
Zai Lab Limited (ZLAB)
RNA logo
Avidity Biosciences (RNA)

FAQ

  • What is the ticker symbol for Organon & Co?
  • Does Organon & Co pay dividends?
  • What sector is Organon & Co in?
  • What industry is Organon & Co in?
  • What country is Organon & Co based in?
  • When did Organon & Co go public?
  • Is Organon & Co in the S&P 500?
  • Is Organon & Co in the NASDAQ 100?
  • Is Organon & Co in the Dow Jones?
  • When was Organon & Co's last earnings report?
  • When does Organon & Co report earnings?
  • Should I buy Organon & Co stock now?

What is the ticker symbol for Organon & Co?

The ticker symbol for Organon & Co is NYSE:OGN

Does Organon & Co pay dividends?

Yes, Organon & Co pays dividends. The last payment was $0.28, with an ex-dividend date on February 24, 2025

What sector is Organon & Co in?

Organon & Co is in the Healthcare sector

What industry is Organon & Co in?

Organon & Co is in the Drug Manufacturers - General industry

What country is Organon & Co based in?

Organon & Co is headquartered in United States

When did Organon & Co go public?

Organon & Co's initial public offering (IPO) was on May 14, 2021

Is Organon & Co in the S&P 500?

No, Organon & Co is not included in the S&P 500 index

Is Organon & Co in the NASDAQ 100?

No, Organon & Co is not included in the NASDAQ 100 index

Is Organon & Co in the Dow Jones?

No, Organon & Co is not included in the Dow Jones index

When was Organon & Co's last earnings report?

Organon & Co's most recent earnings report was on Feb 13, 2025

When does Organon & Co report earnings?

The next expected earnings date for Organon & Co is May 2, 2025

Should I buy Organon & Co stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions